Advertisement
Screener

Perrigo Company plc (PRGO) EBITDA

Perrigo Company plc (PRGO) EBITDA

  • 2026-06-27: Basis Reported; EBITDA $119.30M*; Operating income $23.50M; Depreciation and amortization $95.80M*.
  • 2026-03-28: Basis Reported; EBITDA -$289M; Operating income (m); Depreciation and amortization (m).
  • 2025-12-31: Basis Reported; EBITDA -$1.2B; Operating income (m); Depreciation and amortization (m).
  • 2025-09-27: Basis Reported; EBITDA $158M; Operating income (m); Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history
2012-06-30 to 2026-03-28
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-27Reported$119.30M*$23.50M$95.80M*$1.02B11.66%*$14.30M*$82.60M*$708.90M$23.70M(m)$16.90M
2026-03-28Reported-$289M(m)(m)(m)-29.82%$13.80M-$113.60M$643.70M$24.60M(m)-$18.70M
2025-12-31Reported-$1.2B(m)(m)(m)-108.26%(m)(m)(m)(m)(m)(m)
2025-09-27Reported$158M(m)(m)(m)15.14%$21.90M*$51.70M*$666.20M$24.90M(m)$9.70M
2025-06-28Reported$131.7M(m)(m)(m)12.47%$19.20M*$75.90M*$693.40M$22.00M(m)$3.70M
2025-03-29Reported$126.8M(m)(m)(m)12.15%$25.50M-$64.50M$651.60M$26.70M(m)$8.20M
2024-12-31Reported$194.5M(m)(m)(m)17.09%(m)(m)(m)(m)(m)(m)
2024-09-28Reported$162.7M(m)(m)(m)14.96%$27.10M*$42.20M*$683.10M$26.00M(m)$39.40M
2024-06-29Reported$55.4M(m)(m)(m)5.20%$28.40M*$9.50M*$670.80M$29.40M(m)$31.70M
2024-03-30Reported$26.2M(m)(m)(m)2.42%$25.10M-$1.40M$724.40M$29.00M(m)-$102.70M
2023-12-31Reported$70.3M(m)(m)(m)6.08%(m)(m)(m)(m)(m)(m)
2023-09-30Reported$153.10M*$62.10M$91.00M*$1.12B13.62%*$31.80M*$124.50M*$712.60M$29.60M(m)$3.80M
2023-07-01Reported$150.70M*$56.80M$93.90M*$1.19B12.63%*$20.00M*$52.90M*$765.10M$32.20M(m)$13.60M
2023-04-01Reported$137.2M(m)(m)(m)11.61%$23.20M$19.40M$767.90M$31.10M(m)$5.40M
2022-12-31Reported$128.1M(m)(m)(m)11.09%(m)(m)(m)(m)(m)(m)
2022-10-01Reported$121.60M*$33.10M$88.50M*$1.10B11.05%*$21.30M*$59.20M*$737.30M$29.80M(m)$48.60M
2022-07-02Reported$76.60M*-$6.90M$83.50M*$1.12B6.83%*$28.40M*-$16.90M*$749.60M$31.50M(m)-$43.40M
2022-04-02Reported$91.2M(m)(m)(m)8.49%$20.30M$79.10M$736.70M$29.30M(m)-$11.70M
2021-12-31Reported$120.1M(m)(m)(m)10.87%(m)(m)(m)(m)(m)(m)
2021-10-02Reported$511.80M*$438.30M$73.50M*$1.04B49.08%*$42.00M*$343.80M*$706.30M$27.60M(m)$442.80M
2021-07-03Reported-$51.00M*-$125.90M$74.90M*$981.10M-5.20%*$23.00M*-$82.30M*$632.10M$33.00M(m)-$45.20M
2021-04-03Reported$141.8M(m)(m)(m)14.04%$45.40M$200.00K$641.60M$31.10M(m)$14.20M
2020-12-31Reported$137.7M(m)(m)(m)13.07%(m)(m)(m)(m)(m)(m)
2020-09-26Reported$175.40M*$78.50M$96.90M*$1.00B17.49%*$44.20M*$63.10M*$633.30M$30.40M(m)$22.00M
2020-06-27Reported$157.40M*$62.70M$94.70M*$948.80M16.59%*$26.30M*$290.90M*$601.60M$30.40M(m)$3.10M
2020-03-28Reported$179.5M(m)(m)(m)16.57%$33.80M$171.80M$689.60M$27.90M(m)-$200.00K
2019-12-31Reported$66M(m)(m)(m)18.58%(m)(m)(m)(m)(m)(m)
2019-09-28Reported$156.40M*$54.40M$102.00M*$1.19B13.13%*$35.60M*$140.00M*$778.30M$44.00M(m)$5.10M
2019-06-29Reported$149.90M*$55.00M$94.90M*$1.15B13.05%*$33.60M*$63.80M*$718.20M$43.90M(m)$18.00M
2019-03-30Reported$198.9M(m)(m)(m)16.93%$21.10M$94.50M$725.70M$40.20M(m)$17.00M
2018-12-31Reported$207.1M(m)(m)(m)17.33%(m)(m)(m)(m)(m)(m)
2018-09-29Reported-$15.80M*-$122.00M$106.20M*$1.13B-1.39%*$23.50M*$144.00M*$708.30M$43.70M(m)-$11.50M
2018-06-30Reported$203.00M*$94.70M$108.30M*$1.19B17.11%*$19.90M*$82.30M*$715.40M$91.90M(m)$19.10M
2018-03-31Reported$265.8M(m)(m)(m)21.84%$13.40M$172.40M$724.30M$38.40M(m)$29.70M
2017-12-31Reported$270.3M(m)(m)(m)21.07%(m)(m)(m)(m)(m)(m)
2017-09-30Reported$274.70M*$162.40M$112.30M*$1.23B22.31%*$18.00M*$196.70M*$733.50M$38.40M(m)$84.20M
2017-07-01Reported$260.20M*$148.80M$111.40M*$1.24B21.02%*$15.20M*$90.80M*$733.30M$42.60M(m)-$6.70M
2017-04-01Reported$237.9M(m)(m)(m)19.92%$22.00M$194.50M$729.60M$39.80M(m)$24.20M
2016-12-31Reported-$366M(m)(m)(m)-27.49%(m)(m)(m)(m)(m)(m)
2016-10-01Reported-$1.35B*-$1.47B$114.70M*(m)(m)$27.50M*$219.00M*$777.10M$50.20M(m)-$311.80M
2016-07-02Reported$298.80M*$184.80M$114.00M*(m)(m)$22.40M*$131.20M*$794.00M$47.00M(m)-$277.90M
2016-04-02Reported-$121.9M(m)(m)(m)-9.05%$34.70M$98.50M$814.20M$45.30M(m)$39.10M
2015-09-26Reported$364M(m)(m)(m)27.07%$38.60M$136.00M$737.90M$41.60M(m)$33.90M
2015-06-27Reported$29M(m)(m)(m)2.51%$57.10M*$383.20M*$814.20M$62.60M(m)$82.70M
2015-03-28Reported$326.9M(m)(m)(m)31.16%$31.90M$180.20M$597.80M$35.40M(m)$12.00M
2014-12-27Reported$311.50M*$184.40M$127.10M*(m)(m)$16.30M*$272.60M*$687.90M$53.20M(m)$14.50M
2014-09-27Reported$263.8M(m)(m)(m)27.72%$31.70M$195.10M$629.70M$36.60M(m)$12.30M
2014-06-28Reported$170.4M(m)(m)(m)17.08%(m)(m)(m)(m)(m)(m)
2014-03-29Reported$230.50M*$103.30M$127.20M*(m)(m)$42.20M*$180.50M*$689.20M$44.70M(m)$14.60M
2013-12-28Reported$149.30M*$86.60M$62.70M*(m)(m)$37.40M*$121.60M*$618.30M$37.50M(m)-$27.00M
2013-09-28Reported$227.4M(m)(m)(m)24.36%$40.40M$98.70M$577.10M$32.30M(m)$45.90M
2013-06-29Reported$227.5M(m)(m)(m)23.52%(m)(m)(m)(m)(m)(m)
2013-03-30Reported$221.50M*$178.60M$42.90M*(m)(m)$24.20M*$150.50M*$588.40M$28.50M(m)$48.20M
2012-12-29Reported(m)$163.90M(m)(m)(m)(m)(m)$575.80M$28.30M(m)$39.50M

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported-$784.7M(m)(m)(m)-18.45%$93.40M$238.50M$2.76B$95.40M(m)$104.40M
2024-12-31Reported$438.8M(m)(m)(m)10.03%$118.30M$362.90M$2.83B$112.20M(m)$80.00M
2023-12-31Reported$511.4M(m)(m)(m)10.98%$101.70M$405.50M$2.98B$122.50M(m)-$3.90M
2022-12-31Reported$417.5M(m)(m)(m)9.38%$96.40M$307.30M$3.00B$123.10M(m)-$8.20M
2021-12-31Reported$722.6M(m)(m)(m)17.46%$152.10M$156.30M$2.72B$122.00M(m)$389.60M
2020-12-31Reported$650M(m)(m)(m)15.90%$170.40M$636.20M$2.59B$121.70M(m)-$38.30M
2019-12-31Reported$571.2M(m)(m)(m)14.76%$137.70M$387.80M$2.44B$119.20M(m)-$10.70M
2018-12-31Reported$660.1M(m)(m)(m)13.95%$102.60M$593.00M$2.90B$218.60M(m)$159.60M
2017-12-31Reported$1.04B(m)(m)(m)21.09%$88.60M$698.90M$2.97B$167.70M(m)$160.50M
2016-12-31Reported-$1.54B(m)(m)(m)-29.21%$106.20M$654.90M$3.23B$184.00M(m)-$835.50M
2015-09-26Rolling$1.19B*$742.40M*$452.40M*(m)(m)$143.90M*$972.00M*$2.84B*$192.80M*(m)$143.10M*
2015-06-27Reported$931.2M(m)(m)(m)22.03%$137.00M$855.20M$2.58B$187.80M(m)$124.20M
2015-06-27Rolling$1.11B*$704.30M*$403.60M*(m)(m)$137.00M*$1.03B*$2.73B*$187.80M*(m)$121.50M*
2014-06-28Reported$777.5M(m)(m)(m)19.86%$171.60M$633.00M$2.46B$152.50M(m)$70.80M
2013-06-29Reported$839.3M(m)(m)(m)23.71%$104.10M$553.80M$2.26B$115.20M(m)$165.80M
2012-06-30Reported$704.5M(m)(m)(m)22.20%$120.20M$513.40M$2.08B$105.80M(m)$119.00M

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
Generate Biomedicines, Inc. (GENB)United States$2.052B
UroGen Pharma Ltd. (URGN)$2.015B-18.42
Nuvation Bio Inc. (NUVB)United States$2.007B-13.12
Biohaven Ltd. (BHVN)United States$1.990B-3.83
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Braveheart Bio, Inc. (BRVE)United States$2.106B
Bausch Health Companies Inc. (BHC)$2.113B-1.68
AGIOS PHARMACEUTICALS, INC. (AGIO)United States$1.962B-5.38